BusinessEmergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 GoalsBy Nasdaq OMXFeb 23, 2017, 9:16 PM UTC
BusinessEmergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 GoalsBy Nasdaq OMXFeb 23, 2017, 9:16 PM UTC
BusinessEmergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a Conference Call on February 23, 2017By Nasdaq OMXFeb 9, 2017, 12:00 PM UTC
BusinessEmergent BioSolutions to Participate in First Quarter 2017 Investor ConferencesBy Nasdaq OMXDec 29, 2016, 9:15 PM UTC
BusinessDEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Emergent BioSolutions Inc. Of Upcoming DeadlineBy Nasdaq OMXSep 1, 2016, 7:10 PM UTC
BusinessSHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBSBy Nasdaq OMXAug 31, 2016, 7:51 PM UTC
